DealShot

DealShot: Matrix Leads $14M Series B Round In Chinese Vaccine Supplier SA Biotech

Follow Us:
LinkedIn
Twitter
YouTube
Facebook
Weibo

China Money Network’s DealShot provides detailed information on venture capital and private equity deals in China on a daily basis.

Here you can find out where Chinese investors have been investing their money each workday.

CompanyRoundLead InvestorParticipantsSectorHeadquarters
SA BiotechSeries AMatrix Partners ChinaApex CapitalHealthcareSuzhou
ZhihuSeries EundisclosedMedia & EntertainmentBeijing
UnisoundSeries C+China Internet Investment FundCICC Jiacheng Investment Management, JIC Capital Management (Tianjin) Ltd.AI & RoboticsBeijing
Jianxiaochi We ClassPre-AHeima Lanfeng FundZijing CapitalEducationBeijing
eduBot.cnSeries AundisclosedAI & RoboticsSuzhou
Che300.comSeries DundisclosedE-commerceNanjing
Newtop100.comSeries A+Wu Capital, Hillhouse CapitalMedia & EntertainmentBeijing
NaxionsSeries A+IQVIAHealthcareBeijing
ChezhubangSeries A+ZSY CapitalBlueflame CapitalTransportation & SpaceBeijing
GipproAngel RoundCowin CapitalE-commerceShenzhen
WebullSeries BBojiang CapitalMobai Capital, Dongfang Hongdao Capital, Divine CapitalFintechChangsha
Dr.XingAngel RoundLefit, Qingniao SportsSports
Qianhai YuandaoPre-ASequoia Capital ChinaFintechShenzhen
GuangxindaiSeries BXingbang CapitalShandong Oriental Ocean GroupFintechBeijing
Suning SportsSeries AAlibaba Group, Goldman SachsEvergrande Group, Yunfeng Capital, Sensetime, Sports Industrial Fund of Zhejiang Province, CCB International, Minsheng Bank International, ABC InternationalSportsNanjing
 


Related News








Leave a Reply

Your email address will not be published. Required fields are marked *